Trials / Active Not Recruiting
Active Not RecruitingNCT04380350
Trenza Embolization Device for Intrasaccular Aneurysm Treatment
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Stryker Neurovascular · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Post-Market Clinical Follow-up study is to assess the safety and performance of the Trenza in the treatment of intracranial aneurysms.
Detailed description
Prospective, multi-center, single-arm, post-market follow-up study conducted in Europe for the treatment of patients with saccular intracranial aneurysms.
Conditions
Timeline
- Start date
- 2020-12-17
- Primary completion
- 2026-09-30
- Completion
- 2027-03-30
- First posted
- 2020-05-08
- Last updated
- 2025-04-25
Locations
18 sites across 7 countries: Austria, Finland, France, Germany, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT04380350. Inclusion in this directory is not an endorsement.